Harish Mahalingam, Phd
manger
Seema Cotton Development
Mexico
Biography
Category Medical Affairs Lead, Skin Health Category Company NameGSK Consumer Healthcare Dates Employed2015 – Present Employment Duration2 yrs LocationWarren, NJ GSK Director, New Product Research, Skin Health Category Company NameGSK Dates Employed2012 – 2015 Employment Duration3 yrs LocationParsippany, NJ Novartis Consumer Health Director, Global Medical Affairs Company NameNovartis Consumer Health Dates Employed2008 – 2012 Employment Duration4 yrs LocationParsippany, NJ • Category Experience: Dermatology (Lamisil, Fenistil, Keri), Topical Analgesics (Voltaren Rx), Digestive Health (Prevacid24Hr, Benefiber, Pantoloc Control) • Key Accomplishments:  Revitalization of the Lamisil Brand - with new claims positioning (On pack, TV advertising)  Launch of the therapeutic skin care line- Tensylase- Direct Response TV model  Relaunch of the Keri range of moisturizers with the new “Continuous Moisturization†platform  Medical Communication strategy- Benefiber, Prevacid24HR (US) and Pantoloc Control (EU)  Health Outcome studies in US and Europe- for a new innovative product
Research Interest
Category Medical Affairs Lead, Skin Health Category Company NameGSK Consumer Healthcare Dates Employed2015 – Present Employment Duration2 yrs LocationWarren, NJ GSK Director, New Product Research, Skin Health Category Company NameGSK Dates Employed2012 – 2015 Employment Duration3 yrs LocationParsippany, NJ Novartis Consumer Health Director, Global Medical Affairs Company NameNovartis Consumer Health Dates Employed2008 – 2012 Employment Duration4 yrs LocationParsippany, NJ • Category Experience: Dermatology (Lamisil, Fenistil, Keri), Topical Analgesics (Voltaren Rx), Digestive Health (Prevacid24Hr, Benefiber, Pantoloc Control) • Key Accomplishments:  Revitalization of the Lamisil Brand - with new claims positioning (On pack, TV advertising)  Launch of the therapeutic skin care line- Tensylase- Direct Response TV model  Relaunch of the Keri range of moisturizers with the new “Continuous Moisturization†platform  Medical Communication strategy- Benefiber, Prevacid24HR (US) and Pantoloc Control (EU)  Health Outcome studies in US and Europe- for a new innovative product
